Cardiac Amyloidosis – Everything You Need to Know About Causes, Symptoms, and Treatment Options
Have you ever wondered what happens when your heart starts accumulating abnormal proteins? Cardiac amyloidosis is a complex condition that does just that, affecting the normal structure and function of your heart. In this article, you will discover the causes, symptoms, and treatment options for this challenging disease. Whether you are a patient or just curious to learn more, the information presented will help you better understand this condition and its impact on cardiovascular health.
What is Cardiac Amyloidosis and How Does it Occur
Cardiac amyloidosis is a condition in which abnormal protein deposits called amyloid accumulate in your heart tissue. This buildup affects the normal structure and function of the heart. Amyloid deposits form in the walls of the heart chambers, heart valves, and the spaces around blood vessels. These deposits lead to thickening of the ventricular and atrial walls, affecting the heart’s ability to fill with blood and pump it efficiently.
Cardiac amyloidosis usually occurs in the context of a systemic disease called amyloidosis. The main types affecting the heart are AL amyloidosis (light chain) and ATTR amyloidosis (transthyretin). AL amyloidosis is caused by a disorder of plasma cells in the bone marrow, while ATTR amyloidosis can be hereditary or acquired (senile form).
Factors that increase the risk of developing cardiac amyloidosis include advanced age (over 60-70 years), male sex, certain chronic inflammatory diseases, and a family history of hereditary amyloidosis. Long-term dialysis can also be a risk factor. Symptoms appear gradually as amyloid deposits accumulate and affect cardiac function.
Coenzyme Q10 plays an important role in the health of the heart and cardiovascular system. It is a powerful antioxidant that helps protect heart cells from oxidative stress. Additionally, coenzyme Q10 is essential for cellular energy production, which is crucial for optimal heart muscle function. Premium Coenzyme Q10 100mg can be beneficial for your heart health, providing energy support and antioxidant protection. Studies have shown that coenzyme Q10 supplementation can improve cardiac function and quality of life in patients with heart failure or cardiac amyloidosis.
[cta_produs style=”style_1″ product=”298904″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/02/1.-amiloidoza-cardiaca-coenzima-q10.jpg”]
Types of Cardiac Amyloidosis
There are several types of cardiac amyloidosis, depending on the protein that forms amyloid deposits in your heart. The most common form is AL amyloidosis, caused by the deposition of excess immunoglobulin light chains produced by abnormal plasma cells in the bone marrow. This particularly affects the heart, kidneys, and nervous system.
ATTR amyloidosis can be hereditary, caused by genetic mutations of the TTR gene, or acquired (senile form), which occurs in the elderly due to the deposition of normal transthyretin. More rarely, you may encounter AA amyloidosis (secondary), which occurs as a result of chronic inflammatory diseases, or β2-microglobulin amyloidosis, which can affect the heart in patients on chronic dialysis.
Regardless of the type of amyloid deposited, the consequences at the cardiac level are similar: thickening of the ventricular walls and interventricular septum, diastolic and later systolic dysfunction, arrhythmias, and progressive heart failure. Identifying the specific type of cardiac amyloidosis is essential for establishing the prognosis and choosing appropriate treatment.
Macroglossia and Cardiac Amyloidosis – How They Can Be Recognized and What Symptoms They Present
Macroglossia (enlargement of the tongue) is an important manifestation of amyloidosis. You can recognize macroglossia by the visible increase in your tongue’s size, the wavy appearance of its edges, and difficulties with speech or swallowing. You might feel your tongue “swollen” in your mouth.
The main symptoms of cardiac amyloidosis include dyspnea (shortness of breath), especially with exertion, fatigue and weakness, edema (swelling) of the lower limbs, palpitations, and arrhythmias. You may also experience dizziness, syncope, and chest pain (angina). It is important to pay attention to these signs and communicate them to your doctor.
In addition to macroglossia, other clues that may suggest the presence of cardiac amyloidosis include bilateral carpal tunnel syndrome, purplish spots around the eyes, orthostatic hypotension, and unexplained weight loss. Early recognition of these signs and symptoms is essential for prompt diagnosis and treatment of your condition.
Diagnosing the Condition – Tests and Analyses for Cardiac Amyloidosis
To diagnose cardiac amyloidosis, your doctor will recommend a series of tests and analyses. These include blood and urine tests to check for free light chains and measure cardiac biomarkers. You will also undergo imaging studies such as echocardiography, which reveals thickening of the ventricular walls, and cardiac MRI, which can detect amyloid deposits.
An important test is myocardial scintigraphy with radiolabeled pyrophosphate, which is particularly useful for diagnosing ATTR amyloidosis. If hereditary amyloidosis is suspected, your doctor may recommend genetic testing to identify mutations in the TTR gene. In some cases, a biopsy of abdominal adipose tissue or even an endomyocardial biopsy may be necessary to confirm the diagnosis.
It is important to know that the accurate interpretation of these test results requires experience and collaboration among different specialists. Do not hesitate to ask questions and request further explanations from your doctor regarding the significance of each individual test.
Is Amyloidosis Curable? What is the Treatment for Cardiac Amyloidosis?
Currently, cardiac amyloidosis cannot be completely cured, but there are treatments that can slow the progression of the disease and alleviate your symptoms. The main goal of treatment is to reduce the production of amyloid proteins and manage the cardiac complications you experience.
Treatment options include chemotherapy, particularly used for AL amyloidosis, and specific medications such as tafamidis for ATTR amyloidosis. Depending on your condition, your doctor may also recommend symptomatic treatment for heart failure, such as diuretics or beta-blockers. In severe cases, implantable cardiac devices or even heart transplantation may be considered.
It is important to understand that cardiac amyloidosis treatment must be personalized according to the specific type of amyloidosis you have, the stage of the disease, and your overall condition. Although amyloidosis is not completely curable, new targeted therapies and multidisciplinary approaches have significantly improved patients’ quality of life and survival in recent years.
Prognosis and Quality of Life for Patients with Cardiac Amyloidosis
The prognosis of a patient with cardiac amyloidosis depends on several factors, including the type of amyloidosis, the degree of cardiac involvement at the time of diagnosis, and the response to treatment. Although in the past the prognosis was guarded, early diagnosis and modern treatments have significantly improved prospects for patients.
Quality of life can be affected by symptoms of heart failure, arrhythmias, and side effects of treatments. However, proper management can significantly improve your well-being. It is important to strictly follow the treatment plan, closely monitor your symptoms, and communicate regularly with your medical team.
Do not forget that psychological support and education about the disease are crucial aspects of care. Participation in support groups and maintaining a positive attitude can have a significant impact on your quality of life. With adequate care and a proactive approach to your health, you can maintain a good quality of life for an extended period.
Cardiac amyloidosis is a complex condition that requires a multidisciplinary and personalized approach. Although the diagnosis may be overwhelming, advances in understanding the disease and treatment options offer hope. It is crucial to stay informed, strictly follow medical recommendations, and maintain open communication with your healthcare team.
Your next steps include close monitoring of symptoms, active participation in treatment decisions, and adopting a healthy lifestyle to support cardiovascular health. Do not hesitate to seek emotional support and join patient support groups. With a proactive approach and adequate care, you can effectively manage cardiac amyloidosis and maintain a good quality of life.
References:
1. Maurer MS, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379(11):1007-1016.
2. Gillmore JD, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404-2412.
3. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649.
4. Gertz MA, et al. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. J Am Coll Cardiol. 2015;66(21):2451-2466.
Photo source: Shutterstock.com